BSE filing, NSE: MAGNUM. Summary written from the filing by ALFA Finder's alert engine.
Magnum Ventures Ltd: key numbers
- Share price
- ₹18.28
- Market cap
- ₹125.1 Cr
- Revenue (annual)
- ₹465.0 Cr
- Net profit (annual)
- ₹-11.38 Cr
- P/E (TTM)
- -83.5×Sector 36.4×
- Promoter holding
- 55.21%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Magnum Ventures Ltd
All →Magnum Ventures Debt & Borrowing: ₹60 Cr
Magnum Ventures entered a Rs. 60 Crore term loan agreement with Tata Capital Limited, secured by hotel assets and promoter guarantees. Disbursement is subject to approvals and a pari passu letter from TFCI.
- Value
- ₹60.00 Cr
- Execution
- 135 months
Magnum Ventures Merger & Restructuring
Magnum Ventures Limited announced a NCLT-convened meeting on November 20, 2026, to approve a Scheme of Arrangement. The scheme involves demerging a business into Magnum Paperz Limited.
Magnum Ventures Other Announcement
Magnum Ventures Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Magnum Ventures Debt & Borrowing
Magnum Ventures Limited has fixed October 16, 2026, as the record date for the upcoming interest payment on its non-convertible debentures.
Magnum Ventures Debt & Borrowing: ₹1.6 Cr
Magnum Ventures Ltd confirmed the monthly interest payment of Rs. 1.60 Crore across four tranches of listed NCDs. Payments were completed on September 24, 2026, ahead of the due date.
- Value
- ₹1.60 Cr
Magnum Ventures Debt & Borrowing: ₹3.23 Cr
Magnum Ventures Limited paid Rs. 1.60 Crore in NCD interest and partial redemption. This fulfills debt obligations for debentures under ISINs INE387I07013 and INE387I07021.
- Value
- ₹3.23 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.